Expression of Inducible Nitric Oxide Synthase in Colorectal Cancer and Its Association with Prognosis

References

• Weninger W, Rendl M, Pammer J, Mildner M, Tschugguel W, Schneeberger C, Stürzl M, Tschachler E. Nitric oxide synthases in Kaposi’s sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest 1998;78:949–55.
   Google Scholar
• Knowles RG, Moncada S. Nitric oxide synthase in mammals. Biochem J 1994;298:249–58.
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109–42.
   Google Scholar
• Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998;15:1897–1903.
   Google Scholar
• Duenas-Gonzalez A, Isales CM, del Mar Abad-Hernandez M, Gonzalez-Sarminento R, Sagueza O, Rodriguez-Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod Pathol 1997;10:645–9.
   Google Scholar
• Rajnakova A, Goh PM, Chan ST, Ngoi SS, Alponat A, Moochala S. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 1997;18:1841–5.
   PubMed Web of Science ®Google Scholar
• Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90:587–96.
   PubMed Web of Science ®Google Scholar
• Liu C-Y, Wang C-H, Chen T-C, Lin H-C, Yu C-T, Kuo H-P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998;78:534–41.
   Google Scholar
• Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998; 15:334–41.
   Google Scholar
• Jansson TO, Morcos E, Brundin L, Bergerheim US, Adolfsson J, Wiklund NP. Nitric oxide synthase activity in human renal cell carcinoma. J Urol 1998;160:556–60.
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Sargent JM, Williamson CJ, Elgie AW. Nitric oxide synthase activity in fresh cells from ovarian tumor tissue: relationship of enzyme activity with clinical parameters of patients with ovarian cancer. Biochem Pharmacol 1998;56:1365–70.
   PubMedGoogle Scholar
• Tschugguel W, Pustelnik T, Lass H, Mildner M, Weninger W, Schneeberger C, et al. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 1999;79:1609–12.
   PubMedGoogle Scholar
• UICC: Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. 4th ed. Berlin: Springer; 1987. p. 52–5.
   Google Scholar
• Turnbull RB, Kyle K, Watson FB, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:400–27.
   Google Scholar
• Hietala KA, Kosma V-M, Syrjänen KJ, Kellokoski JK. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2 and HPV type in cervical intraepithelial neoplasia. J Pathol 1997;183: 305–10.
   Google Scholar
• Ropponen KM, Kellokoski JK, Lipponen PK, Pietilainen T, Eskelinen MJ, Alhava EM, et al. p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br J Cancer 1999;81:133–40.
   PubMedGoogle Scholar
• Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, et al. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 1997;15:3111–20.
   PubMed Web of Science ®Google Scholar
• Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M. Prognostic value of tumour infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318–24.
   Google Scholar
• Haapasalo H, Collan Y, Atkin NB, Pesonen E, Seppa A. Prognosis of ovarian carcinomas: prediction by histoquantitative methods. Histopathology 1989;15:167–8.
   Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1992; 51:556–61.
   Google Scholar
• Cox DR. Regression models and life tables with discussion. J R Stat Soc B 1972;34:187–92.
   Google Scholar
• Moochala S, Chatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171–4.
   PubMedGoogle Scholar
• Tozer GM, Everett SA. Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications. Clin Oncol 1997;9: 357–64.
   Google Scholar
• Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998;17:107–18.
   PubMed Web of Science ®Google Scholar
• Miles DW, Happerfield LC, Rubens RD. Localisation of nitric oxide synthase (NOS) isoforms and co-expression of the low affinity IgE receptor (CD23) in primary breast cancer. Proc Am Assoc Cancer Res 1996;37: 238.
   Google Scholar
• Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Harrington AM, et al. Relationship between p53 mutations and inducible nitric oxide synthase in human colorectal cancer. J Natl Cancer Inst 1999;91:86–8.
   PubMed Web of Science ®Google Scholar
• Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol 1999;161:630–4.
   PubMed Web of Science ®Google Scholar
• DiNapoli MR, Calderon CL, Lopez DM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med 1996;183:1323–9.
   Google Scholar
• Gee MS, Sarkisian CJ, El-Deiry WS. Identification of a novel AP-2 consensus DNA binding site. Biochem Biophys Res Commun 1998;243: 307–16.
   Google Scholar
• Rey MJ, Fernandez PL, Jares P, Munoz M, Nadal A, Peiro N, et al. p21 WAF/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J Pathol 1998;184:265–71.
   PubMedGoogle Scholar
• Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 1998;4:1371–6.
   PubMed Web of Science ®Google Scholar
• Gansauge S, Nussler AK, Beger HG, Gansauge F. Nitric oxideinduced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and increase of the cyclin-dependent kinase inhibitor p21WAF/CIP1. Cell Growth Differ 1998;9:611–7.
   PubMedGoogle Scholar
• Reveneau S, Arnould L, Genevieve J, Hilpert S, Lejeune P, Saint-Giorgio V, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate and expression of progesterone receptors. Lab Invest 1999;79:1215–25.
   Google Scholar
• Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR, Harris CC. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 1998;95:8823–8.
   PubMed Web of Science ®Google Scholar
• Messmer UK, Ankarcrona M, Nicotera P, Brune P. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23–6.
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352–4.
   Google Scholar
• Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41–4.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Kijima H, Tokunaga T, Tajima T, Himeno S, Kenmochi T, et al. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int J Oncol 1999;14:1069–73.
   PubMedGoogle Scholar
• Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995;181:1333–43.
   PubMedGoogle Scholar
• Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392–6.
   PubMed Web of Science ®Google Scholar
• Bentz BG, Barnes MN, Haines GK, Lurain JR, Hanson DG, Radosevich JA. Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas. Tumor Biol 1997;18:290–300.
   PubMedGoogle Scholar